Literature DB >> 16971563

Changes in disease gene frequency over time with differential genotypic fitness and various control strategies.

P N Thompson1, J A P Heesterbeek, J A M van Arendonk.   

Abstract

A spreadsheet model was constructed to describe the change in allelic frequency over time for a lethal recessive mutation in an animal population. The model allowed relative fitness to differ between genotypes, between sexes, and over time. Whereas a lethal recessive allele is naturally eliminated very slowly from a population, a small selective disadvantage of the heterozygote results in a large increase in the rate of elimination. With selective advantage of the heterozygote through linkage with a production trait or pleiotropy, the allele is never naturally eliminated but tends toward a stable equilibrium frequency. The model was used to investigate various alternative control programs based on the detection of heterozygotes by genotyping and their exclusion from breeding. The programs (genotyping males only, genotyping males and 50% of females, and genotyping all breeding animals) were modeled for various initial heterozygote frequencies, and the results were described in terms of the number of generations, number of tests, and number of culls required to reduce the heterozygote frequency to a predefined level. The model can be used to compare the feasibility and cost of various control strategies and to illustrate clearly to breeders the expected outcomes, as well as the danger of prematurely terminating a control program when there is a selective advantage of the heterozygote.

Entities:  

Mesh:

Year:  2006        PMID: 16971563     DOI: 10.2527/jas.2005-774

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  1 in total

1.  KDM2B is implicated in bovine lethal multi-organic developmental dysplasia.

Authors:  Stefania Testoni; Elena Bartolone; Marco Rossi; Andrea Patrignani; Rémy Bruggmann; Peter Lichtner; Jens Tetens; Arcangelo Gentile; Cord Drögemüller
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.